- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Pricing
- SKY Learn
- Mutual Funds
- Margin Trading
- Financial Planning
- Personal Finance
- Share Trading
- IPO
- Derivatives
- Currencies
- Intraday Trading
- Trading Strategies
- Demat Account
- Commodity
- ETF
Mahamaya Lifesciences IPO
₹1,29,600/1200 shares
Minimum Investment
IPO Details
11 Nov 25
13 Nov 25
₹1,29,600
1200
₹108 to ₹114
BSE
₹70.44 Cr
18 Nov 25
Mahamaya Lifesciences IPO Timeline
Bidding Start
11 Nov 25
Bidding Ends
13 Nov 25
Allotment Finalisation
14 Nov 25
Refund Initiation
17 Nov 25
Demat Transfer
17 Nov 25
Listing
18 Nov 25
Mahamaya Lifesciences Limited
Incorporated in 2002, Mahamaya Lifesciences Limited manufactures, registers, and exports crop protection products and bioproducts that enhance crop and soil health. The company specialises in pesticide formulations and supplies bulk products to leading Indian agrochemical companies and multinational corporations. Its international presence spans the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey.
Mahamaya Lifesciences Limited IPO Overview
Mahamaya Lifesciences Limited is launching its IPO through a book-built issue worth ₹70.44 crore. The issue comprises a fresh offering of 0.56 crore shares, aggregating to ₹64.28 crore, along with an offer for sale of 0.05 crore shares, amounting to ₹6.16 crore. The IPO will open for subscription on 11 November 2025 and close on 13 November 2025, with the allotment expected to be finalised on 14 November 2025. The company’s shares are proposed to be listed on the BSE SME platform, with a tentative listing date set for 18 November 2025.
The price band for the Mahamaya Lifesciences IPO is fixed between ₹108 and ₹114 per share, and the lot size is 1,200 shares. Retail investors can apply for a minimum of two lots (2,400 shares) requiring an investment of ₹2,73,600 at the upper price band, while the minimum application for HNI investors is three lots (3,600 shares), amounting to ₹4,10,400.
Oneview Corporate Advisors Pvt. Ltd. is the Book Running Lead Manager of the issue, while Kfin Technologies Ltd. serves as the Registrar. The Market Maker for the IPO is Mansi Share & Stock Broking Pvt. Ltd.
Mahamaya Lifesciences Limited IPO Details
| Particulars | Details |
| IPO Date | 11 November 2025 to 13 November 2025 |
| Listing Date | 18 November 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹108 to ₹114 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | 61,78,800 shares (aggregating up to ₹70.44 Cr) |
| Fresh Issue | 56,38,800 shares (aggregating up to ₹64.28 Cr) |
| Offer for Sale | 5,40,000 shares (aggregating up to ₹6.16 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,77,66,200 shares |
| Share Holding Post Issue | 2,34,05,000 shares |
| Market Maker Portion | 3,09,600 shares (aggregating up to ₹3.53 Cr) |
Mahamaya Lifesciences Limited IPO Reservation
| Investor Category | Shares Offered |
| QIB | Not more than 50% of the Net Offer |
| Retail | Not less than 35% of the Net Offer |
| NII (HNI) | Not more than 15% of the Net Offer |
Mahamaya Lifesciences Limited IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 2 | 2,400 | ₹2,73,600 |
| Retail (Max) | 2 | 2,400 | ₹2,73,600 |
| S-HNI (Min) | 3 | 3,600 | ₹4,10,400 |
| S-HNI (Max) | 7 | 8,400 | ₹9,57,600 |
| B-HNI (Min) | 8 | 9,600 | ₹10,94,400 |
Mahamaya Lifesciences Limited IPO Promoter Holding
| Shareholding Status | Percentage |
| Pre-Issue | 77.27% |
| Post-Issue | 56.35% |
Mahamaya Lifesciences Limited IPO Valuation Overview
| KPI | Value |
| Earnings Per Share (EPS) | ₹7.29 |
| Price/Earnings (P/E) Ratio | 15.65 (Pre-Issue), 16.25 (Post-Issue) |
| Return on Net Worth (RoNW) | 26.19% |
| Net Asset Value (NAV) | ₹27.82 |
| Return on Equity (ROE) | 34.94% |
| Return on Capital Employed (ROCE) | 23.15% |
| EBITDA Margin | 9.22% |
| PAT Margin | 4.84% |
| Debt to Equity Ratio | 1.08 |
Objectives of the Proceeds
- Purchase of equipment for existing formulation plant – ₹3.75 crore
- Funding capital expenditure for new technical manufacturing plant – ₹29.42 crore
- Construction of warehouse building and purchase of machinery – ₹2.53 crore
- Funding working capital requirement – ₹18.00 crore
- General corporate purposes – balance amount
Key Financials (in ₹ crore)
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 188.35 | 112.07 | 77.88 |
| Revenue | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 12.94 | 5.22 | 3.75 |
| Reserves and Surplus | 31.66 | 23.41 | 18.19 |
| Total Borrowings | 58.11 | 54.63 | 24.37 |
SWOT Analysis of Mahamaya Lifesciences IPO
Strength and Opportunities
- Experienced management and industry expertise
- Expanding global markets and export reach
- Strong supplier and customer relationships
- Growing domestic demand for crop protection products
Risks and Threats
- Moderate profit margins compared to peers
- Dependence on agrochemical regulatory policies
- High competition from global agrochemical firms
- Fluctuating raw material costs and forex risks
Live Mahamaya Lifesciences IPO News
Explore IPO Opportunities
Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
About Mahamaya Lifesciences Limited
Mahamaya Lifesciences IPO Strentgths
- Over two decades of experience in agrochemical manufacturing and crop protection products.
- Diverse portfolio of pesticide formulations and bioproducts catering to multiple agricultural needs.
- Strong relationships with reputed Indian agrochemical firms and multinational corporate clients.
- Expanding international presence across markets like UAE, Egypt, Turkey, and Ethiopia
- IPO funds aimed at capacity expansion, warehouse construction, and working capital enhancement.
- Consistent revenue and profit growth reflecting operational efficiency and financial stability.
- Dedicated R&D focus promoting sustainable, eco-friendly, and high-performance agrochemical solutions.
Peer Group Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (₹) | P/E (x) | RoNW (%) | P/BV Ratio |
| Mahamaya Lifesciences Limited | 7.60 | 7.60 | 27.82 | — | 26.19 | — |
| Peer Group | ||||||
| Nova Agritech Limited | 3.05 | 3.05 | 23.76 | 16.93 | 12.47 | 2.22 |
| Bhagiradha Chemicals & Industries Ltd. | 1.14 | 1.14 | 52.61 | 247.63 | 2.03 | 5.42 |
How to apply IPO with HDFC SKY?
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
FAQs On Mahamaya Lifesciences Limited IPO
How can I apply for Mahamaya Lifesciences Limited IPO?
You can apply via HDFCSky using the UPI-based ASBA facility during the subscription period.
What is the minimum investment required in the Mahamaya Lifesciences IPO?
The minimum investment is ₹2,73,600 for 2,400 shares.
When will Mahamaya Lifesciences Limited list on the exchange?
The tentative listing date is 18 November 2025 on the BSE SME platform.
What is the price range for the Mahamaya Lifesciences IPO?
The price band is fixed between ₹108 and ₹114 per share.
By signing up I certify terms, conditions & privacy policy